trail4life.eu
Trail-4-Life develops tools to diagnose and treat cancer and autoimmune diseases by targeting the TRAIL/DR death-signalling pathway. The approach combines small molecule inhibitors to block the non-canonical signaling and nanovehicles for targeted therapy, improving TRAIL-induced tumor cell death. Technologies include artificial intelligence, machine learning, in silico drug discovery, and experimental work across in vitro, in vivo, flow cytometry and single-cell transcriptomics. It is a multidisciplinary, multinational consortium collaborating with researchers and SMEs, leveraging cancer genomics for design and evaluation.
trail4life.eu
Trail-4-Life develops tools to diagnose and treat cancer and autoimmune diseases by targeting the TRAIL/DR death-signalling pathway. The approach combines small molecule inhibitors to block the non-canonical signaling and nanovehicles for targeted therapy, improving TRAIL-induced tumor cell death. Technologies include artificial intelligence, machine learning, in silico drug discovery, and experimental work across in vitro, in vivo, flow cytometry and single-cell transcriptomics. It is a multidisciplinary, multinational consortium collaborating with researchers and SMEs, leveraging cancer genomics for design and evaluation.